Elite Pharmaceuticals, Inc. is a publicly traded company trading on OTC, led by CEO Nasrat Hakim.
Upcoming earnings announcement for Elite Pharmaceuticals, Inc.
Past 12 earnings reports for Elite Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Q3 2026 | $0.01 | — | $31.6M | — | — |
| Nov 14, 2025 | Q2 2026 | $0.01 | — | $36.3M | — | — |
| Aug 14, 2025 | Q1 2026 | -$0.01 | — | $40.2M | — | — |
| Jun 30, 2025 | Q4 2025 | — | — | — | — | — |
| Feb 13, 2025 | Q3 2025 | -$0.01 | — | $14.4M | — | — |
| Nov 14, 2024 | Q2 2025 | -$0.01 | — | $18.9M | — | — |
| Aug 14, 2024 | Q1 2025 | $0.00 | — | $18.8M | — | — |
| Jul 1, 2024 | Q4 2024 | $0.00 | — | $17.9M | — | — |
| Feb 14, 2024 | Q3 2024 | $0.00 | — | $15.5M | — | — |
| Nov 14, 2023 | Q2 2024 | $0.01 | — | $14.2M | — | — |
| Aug 14, 2023 | Q1 2024 | $0.00 | — | $9.0M | — | — |
| Jun 29, 2023 | Q4 2023 | $0.00 | — | $8.6M | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.